相关实验视频

Updated: Jun 9, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

在临床前模型中,PAbs的抗瘤活性是由针对HER3的基于蛋白质的新型候选疫苗免疫生成的

Ernesto Bermúdez-Abreut¹, Gretchen Bergado Báez¹, Melissa Martínez Pestano¹

¹Immunology and Immunotherapy Division, Center of Molecular Immunology (CIM), Havana, Cuba.

Frontiers in oncology

|October 31, 2024

概括

一种针对HER3受体的新型疫苗成功产生了多克隆抗体 (PAbs),在临床前模型中显示出抗瘤作用. 这种HER3疫苗显示出治疗HER3表达性癌症的前景.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

HER3是癌症治疗的验证标,但目前还没有批准针对 HER3 的药物.
现有的向HER3的药物主要是单克隆抗体 (MAbs),对活性免疫治疗的探索有限.
疫苗中的多克隆抗体 (PAbs) 可以模仿MAb效应器功能,例如连接体中和受体降解.

研究的目的:

开发和评估一种基于蛋白质子单位的疫苗,针对HER3.的细胞外域 (ECD).
评估HER3疫苗和诱导PAbs的免疫性和抗瘤疗效.

主要方法:

开发了一种针对小鼠ErbB3-ECD的单价疫苗.
免疫小鼠克服自我耐受性,并诱导ErbB3特异性的PAbs.
在实验室和体内使用ErbB3过度表达瘤模型评估疫苗和PAB疗效.

主要成果:

在小鼠中,HER3-ECD疫苗成功诱导了ErbB3特异PAbs的高标位.
诱导的PAbs在体外对人类上皮质瘤细胞系表现出细胞毒性.
疫苗和诱导的PAbs在体内显示出显著的抗瘤作用.

结论:

HER3是一种可行的瘤抗原,其通过PAbs的向可以复制MAb机制.
开发的HER3-ECD候选疫苗具有免疫性,对表达HER3的癌症具有治疗潜力.

关键词:

这是ErbB3B3的意思.在HER3中,HER3是HER3.这就是PAbs的PAbs.它具有抗瘤效果的作用.癌症疫苗癌症疫苗免疫疗法免疫疗法

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...